Enax-Krumova Elena K, Lenz Melanie, Frettlöh Jule, Höffken Oliver, Reinersmann Annika, Schwarzer Andreas, Westermann Andrea, Tegenthoff Martin, Maier Christoph
Departments of Neurology, BG University Hospital Bergmannsheil GmbH, Ruhr University Bochum, Bochum, Germany.
Pain Medicine, BG University Hospital Bergmannsheil GmbH, Ruhr University Bochum, Germany.
Pain Med. 2017 Jan 1;18(1):95-106. doi: 10.1093/pm/pnw147.
The most prominent sensory sign of the complex regional pain syndrome (CRPS) is blunt hyperalgesia, but longitudinal studies on its relation to the outcome of long-term multimodal treatment are lacking.
We examined 24 patients with CRPS type I using standardized Quantitative Sensory Testing on the affected hand and the contralateral hand at baseline and 6 months following treatment. Somatosensory evoked potentials after single and paired-pulse stimulation of the median nerve were performed to assess the paired-pulse suppression (n = 19). Treatment response at follow-up was defined as pain relief > 30% and improved hand function. Statistics: Wilcoxon test, Pearson correlation.
At baseline, similar to previous studies, the pressure pain threshold (PPT) was significantly decreased and the pain response to repeated pinprick stimuli was significantly increased, while all detection thresholds were within the normal range without any difference between the later treatment responders and non-responders. After 6 months of treatment, the PPT increased significantly in the whole study group. However, the pressure hyperalgesia improved only in treatment responders (n = 17, P < 0.05), whereas there was no improvement in non-responders (n = 7). The rest of the sensory profile remained nearly unchanged. There was a correlation between the paired-pulse suppression and the PPT only at follow-up (r = 0.49, P < 0.05), but not at baseline, where low pressure pain threshold was associated with impaired paired-pulse suppression.
Thus, the persistence of blunt hyperalgesia seems to be associated with impaired paired-pulse suppression, both representing maladaptive central nervous changes in CRPS, which may account for the treatment non-response in this subgroup.
复杂性区域疼痛综合征(CRPS)最突出的感觉体征是钝性痛觉过敏,但缺乏关于其与长期多模式治疗结果关系的纵向研究。
我们对24例I型CRPS患者在基线时以及治疗后6个月,使用标准化定量感觉测试对患手和对侧手进行检查。对正中神经进行单脉冲和双脉冲刺激后进行体感诱发电位检查,以评估双脉冲抑制情况(n = 19)。随访时的治疗反应定义为疼痛缓解>30%且手部功能改善。统计学方法:Wilcoxon检验、Pearson相关性分析。
在基线时,与先前研究相似,压力痛阈(PPT)显著降低,对重复针刺刺激的疼痛反应显著增加,而所有检测阈值均在正常范围内,后期治疗反应者和无反应者之间无差异。治疗6个月后,整个研究组的PPT显著升高。然而,压力性痛觉过敏仅在治疗反应者中有所改善(n = 17,P < 0.05),而无反应者(n = 7)则无改善。其余感觉特征几乎保持不变。仅在随访时双脉冲抑制与PPT之间存在相关性(r = 0.49,P < 0.05),而在基线时不存在相关性,此时低压力痛阈与双脉冲抑制受损相关。
因此,钝性痛觉过敏的持续存在似乎与双脉冲抑制受损有关,两者均代表CRPS中适应性不良的中枢神经变化,这可能是该亚组治疗无反应的原因。